- Possible inhibition of ICD therapies by newer generation iPhone 12The Heart Rhythm Society recently published information regarding an important public health issue concerning the newer generation iPhone 12 which can potentially inhibit lifesaving therapy in a patient, particularly while carrying the phone in upper pockets. The…
- BCS Review of ESC Clinical Practice Guidelines: 2020In 2020, new clinical practice guidelines were published by the European Society of Cardiology. The BCS Clinical Standards Group has reviewed the guidelines and written short summaries with a focus on what is new and any important…
- Erythromycin: Caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxabanDrug Safety Update Published 17 December 2020From: Medicines and Healthcare products Regulatory Agency Erythromycin has been associated with events secondary to QT interval prolongation such as cardiac arrest and ventricular fibrillation. Visit Gov.uk website to learn more…
- Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44,000 patientsDr Amit Bhan examines a study on Novel Oral Anticoagulants recently published in the European Heart Journal.
- The Expanding Role of Social Media in Cardiovascular WorkThe following two articles explore the roles social media can play in the cardiovascular sector. From research, to peer-to-peer engagement to recruitment. Social media in cardiovascular medicine: a contemporary review https://academic.oup.com/ehjdh/article/1/1/10/5998381 Using social media to recruit study…
The latest news, topical and relevant articles covering the entire spectrum of cardiology all in one place